Patrick G. Enright, Director at Zenas BioPharma, Inc. (ZBIO), bought 774,530 shares at $17.00 ($7.5M) on 2024-09-16, disclosed to the SEC on 2024-09-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 334,530 | $0 | 0.0% |
| 2 | $17.00 | 440,000 | $7.5M | 100.0% |
| Total | $9.66 avg | 774,530 | $7.5M | 100% |
| Filing → |
| ZBIO | BUY | 2025-10-14 | $2.5M | — | Filing → |
| VERA | BUY | 2025-06-25 | $10.6M | — | Filing → |
| BIOA | BUY | 2024-09-27 | $7.2M | — | Filing → |